← All stocks

ARROWHEAD PHARMACEUTICALS, INC.

ARWR Net selling

CIK 0000879407 #848 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.19M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$1.19M

2 of 2 sales

Net

−$1.19M

−$1.19M against sales at will

By person

14 insiders · 2 transactions

337×

Christopher Anzalone holds 337 times base salary in stock. $331.11M of shares against $981.05K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Anzalone last reported holding, valued at $87.30, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

PERRY MICHAEL S

Director

—

$1.01M (1)

−$1.01M

111,459

0.0789%

$9.73M

−2.9%

OLUKOTUN ADEOYE Y

Director

—

$173.92K (1)

−$173.92K

31,600

0.0224%

$2.76M

+38.3%

Anzalone Christopher Richard

Chief Executive Officer

—

3,792,739

2.69%

$331.11M

+2.1%

O'Brien Patrick

COO

—

547,408

0.3875%

$47.79M

+17.9%

Myszkowski Kenneth Allen

Chief Financial Officer

—

455,433

0.3224%

$39.76M

+13.7%

Hamilton James C

Chief Medical Officer

—

226,958

0.1607%

$19.81M

+10.8%

Apel Daniel Joseph

Chief Financial Officer

—

162,905

0.1153%

$14.22M

+61.3%

GIVEN DOUGLAS B

Director

—

124,167

0.0879%

$10.84M

−4.3%

Ferrari Mauro

Director

—

69,053

0.0489%

$6.03M

+13.6%

Waddill William D.

Director

—

56,563

0.0400%

$4.94M

+18.2%

Lu Hongbo

Director

—

52,012

0.0368%

$4.54M

+70.9%

INGRAM DOUGLAS S

Director

—

46,215

0.0327%

$4.03M

—

Vakiener Victoria

Director

—

35,723

0.0253%

$3.12M

+18.3%

Cohen Matthew Gregory

Director

—

11,882

0.0084%

$1.04M

—

ARROWHEAD PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out